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Abstract: Increasing evidence implicates intervertebral disc (IVD) degeneration as a major contrib-
utor to low back pain. In addition to a series of pathogenic processes, degenerated IVDs become 
vascularized in contrast to healthy IVDs. In this context, angiopoietin (Ang) plays a crucial role and 
is involved in cytokine recruitment, and anabolic and catabolic reactions within the extracellular 
matrix (ECM). Over the last decade, a progenitor cell population has been described in the nucleus 
pulposus (NP) of the IVD to be positive for the Tie2 marker (also known as Ang-1 receptor). In this 
study, we investigated the influence of Ang-1 and Ang-2 on human NP cell (Tie2+, Tie2- or mixed) 
populations isolated from trauma patients during 7 days in normoxia (21% O2) or hypoxia (≤ 5% 
O2). At the end of the process, the proliferation and metabolic activity of the NP cells were analyzed. 
Additionally, the relative gene expression of NP-related markers was evaluated. NP cells showed a 
higher proliferation depending on the Ang treatment. Moreover, the study revealed higher NP cell 
metabolism when cultured in hypoxia. Additionally, the relative gene expression followed, with an 
increase linked to the oxygen level and Ang concentration. Our study comparing different NP cell 
populations may be the start of new approaches for the treatment of IVD degeneration. 
Keywords: intervertebral disc (IVD); nucleus pulposus progenitor cells (NPPCs); angiopoietin-1 re-
ceptor (also known as Tie2); fluorescence-activated cell sorting; hypoxia; normoxia 
s 
1. Introduction 
1.1. Low Back Pain and Intervertebral Disc Degeneration (IVDD) 
Intervertebral disc degeneration is a significant and multifaceted cause of low back 
pain [1]. The so-called “discogenic pain” is described as a major cause of low back pain in 
26–42% of cases [2]. Yet, it is known that the IVD undergoes degenerative changes earlier 
in life than do other tissues of major organ systems [1]. Whilst for the process of aging and 
degeneration, the IVD cells enter a state of cell senescence, showing an altered and often 
more catabolic metabolism [3], oftentimes the nucleus pulposus (NP) is primarily affected 
[3]. Moreover, the IVD possesses a very limited self-healing potential [4,5]. Conventional 
treatment strategies, such as analgetics, physical therapy, or surgical interventions, 
mainly address the symptoms of LBP, while no regeneration mechanisms in the IVD are 
activated [6]. The combination of tissue engineering strategies with stem cell-based ther-
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apies and approaches with native cells have gained significant momentum, being a desir-
able and promising novel treatment opportunity for degenerated IVDs since they aim to 
restore the properties of the IVD and, thus, their biological function [7].  
1.2. Hypoxia vs. Normoxia in the Intervertebral Disc (IVD) 
Another critical aspect in the IVD cell biology is that the NP is avascular, so its cell 
population does not receive a blood supply (nutrients diffuse through the vertebral end-
plates); therefore, oxygen levels in this central area are very low [8,9], causing a hypoxic 
environment [10]. As consequence, these NP cells may have adapted to these conditions. 
An increase in oxygen concentration during IVDD could be considered a pathological 
condition, unlike that observed in other tissues or wound healing [11].  
1.3. Nucleus Pulposus Progenitor Cells (also known as Tie2+ Cells) 
A cell source of current major interest is the tissue-specific Tie2 (also known as TEK 
receptor tyrosine kinase or angiopoietin-1 receptor or CD202b) positive NP progenitor cell 
(NPPC) population. These cells are perfectly adapted to the hypoxic environment and can 
therefore uphold their regenerative potency [12]. Notably, NPPCs are attributed with hav-
ing potential in regenerative medicine because of their remarkable in vitro multipotency 
capability through their osteogenic, chondrogenic, and adipogenic lineages in addition to 
their self-renewal potential [13]. The harsh IVD microenvironment forms an obstacle to 
exogenous cells (such as bone marrow-derived mesenchymal stem cells) to survive and 
exhibit a tissue-regenerative function. Thus, NPPCs might pose a promising target to stim-
ulate and induce tissue repair [14]. However, a major challenge in the NPPC therapy ap-
proach is caused by the decrease in the percentage of the Tie2+ NPPC population with 
aging and the extent of disc degeneration [1]. The methodology for optimized NP cell 
isolation (by cell sorting) and cell expansion are already described [6,15,16]. 
1.4. Tie2 Receptor and Its Ligands; Angiopoietin-1 and Angiopoietin-2 
The receptor tyrosine kinase Tie2 is mainly expressed in endothelial cells and is es-
sential for embryonal and adult angiogenesis and vascular maturation and maintenance 
[17,18] and its also expressed by early hematopoietic cells and subsets of monocytes ex-
press Tie2 [19]. Ang-1–4 are the growth factor ligands of the Tie2 receptor. In this project, 
we focused on Ang-1 and -2, which are mainly produced by vascular smooth muscle cells, 
throughout the entire vascular system, and endothelial cells respectively [20–22]. The 
binding of Ang-1 to its extracellular receptor Tie2 results in autophosphorylation and sub-
sequent activation of downstream signaling pathways including the PI3-kinase/Akt 
[18,19,23]. The Tie2 receptor activation mediates stabilization, remodeling, and repair of 
the vascular system [18,24]. The inactivation of this pathway protects endothelial cells 
from apoptosis and inhibits inflammatory responses [18]. Cell-based Ang-1 gene therapy 
may represent a new strategy for treating various endothelium disorders, including sev-
eral severe human pulmonary diseases [25,26]. Ang-2 fulfills a dual function by acting as 
an agonist or antagonist in a context-dependent manner [17]. while showing similar bio-
logical outcomes to Ang-1. However, it has to be emphasized that they are weaker in po-
tency and kinetics. As a consequence, Ang-2, thus, may act as a partial Ang-1 agonist [17]. 
1.5. The Role of Tie2/Ang-1 and Ang-2 Signaling Pathway in Human NPCs and NPPCs 
Sakai et al. [1] suggested that Tie2 is a sensitive marker of aging and the degeneration 
of IVDs, and therefore is strongly relevant in IVDD. In this study, the elementary role of 
the Tie2/Ang-1 signaling was already demonstrated. Endogenous Ang-1 provides an in-
nate anti-apoptotic effect on human NP cells and is crucial for their survival. Additionally, 
enhancement of the proliferation of Tie2+ populations was achieved when NP cells were 
cultured with Ang-1. More recently, it was discovered that with aging and increasing de-
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generation, the imbalance between the Ang-2/Ang-1 ratio significantly rises [23]. Down-
regulation by Ang can be associated with suppressing cell adhesion and viability and pro-
moting the apoptosis of NPCs; therefore, the blockage of Ang-2 may represent another 
novel therapeutic approach to prevent NPC loss in IVD. 
1.6. Hypothesis and Aims 
This study aimed to investigate the effect of angiopoietin-1 and angiopoietin-2 in 
combination with culture under hypoxia and normoxia on three NP cell populations’ 
(mixed, Tie2- and Tie2+) proliferation, metabolism, and phenotype in the context of IVD 
regenerative medicine. The present work was undertaken to explore the hypothesis that, 
as NP tissue represents a heterogenous cell population, cells will react differently, in a 
dose-dependent effect to Ang-1 and Ang-2 stimulation. Secondly, we hypothesized that 
the variation in the measured parameters within those three cell populations is modified 
under normoxic and hypoxic conditions with or without stimulation with Ang-1 and Ang-
2. 
2. Materials and Methods 
2.1. NPC Isolation 
NP cells were isolated from IVD. The IVDs were obtained from human donors un-
dergoing spinal surgery after trauma (Table 1). Written and informed consent was ob-
tained from all participants. The tissue was dissected into nucleus pulposus tissue (NP), 
annulus fibrosus (AF) tissue, cartilaginous endplate (CEP) tissue, and cut into smaller 
fragments (0.3 cm3). To avoid drying out the sample fragments, a sufficient amount of 
phosphate-buffered salt solution (PBS) was given over the tissue fragments.  
Table 1. Overview of the sex and age of the patient when the sample was collected, IVD tissue location, cell’s passage, and 
IVD status from all patients used in this project. Abbreviations: Th, thoracic; L, lumbar; S, sacrum; P, passage. 
Donor Number Sex Age IVD Level (Indication for Surgery) Cell’s Passage 
1 Female 26 Th12/L1 (Trauma) P3 
2 Female 25 L1/L2 (Trauma) P6 
3 Male 20 L1/L2 (Trauma) P3 
4 Male 24 Th12/L1 (Trauma) P4 
5 Male 24 L3/L4; L4/L5; L5/S1 pooled (Trauma) P6 
6 Female 19 
Th12/L1; L1/L2 
pooled (Trauma) P6 
7 Female 20 Th12/L1; L1/L2 pooled (Trauma) P2 
8 Male 18 L1/L2 (Trauma) P2 
Subsequently, NP tissue samples were centrifuged for 5 min at 500× g (Eppendorf 
Centrifuge 5810, Vaudaux-Eppendorf, Schönenbuch, Switzerland). After centrifugation, 
PBS was removed and the samples were incubated with sterile 0.19% pronase solution 
(#10165921001; Roche Diagnostics, Basel, Switzerland) and digested on a shaker for 60 min 
at 12 rpm. 
After one hour of digestion, tissue digested samples were centrifuged again for 5 min 
at 500× g. After removing the supernatant, the tissues were washed with PBS and digested 
with sterile collagenase type II (255 U/mg; #LS004174; Worthington Biochemical, Inc., Lon-
don, U.K.). A solution of 0.025% collagenase type II was used, diluted in LG-DMEM (low 
glucose Dulbecco’s Modified Eagle Medium (1 g/L; LG-DMEM; #31600-083; Thermo 
Fisher Scientific, Basel, Switzerland) +10% FBS (fetal bovine serum; #10500-064; Gibco Life 
Technologies, Basel, Switzerland). Then, the tissue samples were transferred into T75 
flasks and left on a shaker at 12 rpm for overnight digestion. 
Appl. Sci. 2021, 11, 7144 4 of 18 
 
The following day, cells and the digested tissues were filtered through a 100 μm 
strainer (#431752; Falcon; Becton, Dickinson and Company, Allschwil, Switzerland) to re-
move debris and washed once again with PBS. The cells were then resuspended in a LG-
DMEM complete medium (CM) containing 0.22% sodium hydrogen carbonate (#31437-
500G-R; Sigma-Aldrich, Buchs, Switzerland), 10% FBS, 1 mM sodium pyruvate (#11360-
039; Thermo Fisher Scientific), 1% penicillin/streptomycin/glutamine (#10378-016; P/S/G, 
100 units/mL, 100 μg/mL and 292 μg/mL, respectively; Thermo Fisher Scientific), and 10 
mM HEPES buffer solution (#15630-056; Thermo Fisher Scientific). The NP cell suspension 
was then transferred into T150 culture flasks (#90151; TPP, Trasadingen, Switzerland). 
Furthermore, cells from the AF and CEP tissues were frozen. 
2.2. NPC Expansion 
The cells were expanded with LG-DMEM (CM) supplemented with 2.5 ng/mL of 
FGF-2 (#100-18B, PeproTech, London, U.K.) [13]. The medium was changed twice per 
week. To obtain a sufficient number of cells for future experiments, NP cells were pas-
saged until 100% confluency was reached, which corresponded to about 5–8 days of cul-
ture. 
2.3. NPC Sorting 
As soon as the NP cells reached 90% confluency, most of them were used to be sorted 
into a Tie2+ cell population and a Tie2- cell population with fluorescence-activated cell sort-
ing (FACS) as previously described [6,15,16]. In short, freshly isolated NPCs were incu-
bated with an anti-human Tie2 PE-conjugated monoclonal mouse antibody (#FAB3131P, 
clone 83715, R&D systems) with 2 μL/106 cells for 30 min on ice and protected from light 
in 100 μL of FACS buffer ([PBS] with 0.1% bovine serum albumin (BSA; #A7030-100G; 
Sigma-Aldrich), P/S (100 units/mL and 100 μg/mL; Thermo Fisher Scientific), and 0.5M 
ethylenediaminetetraacetic acid (EDTA; #03610; Fluka, Buchs, Switzerland)). Propidium 
iodide (Sigma-Aldrich) was used to exclude dead cells. Cell sorting was performed by 
FACS Diva III (BD Biosciences) based on the procedure previously reported [6]. The 
mouse IgG1 PE-conjugated antibody (#IC002P, clone 11711, R&D systems) was used as an 
isotype control to set the gate for sorting. The NP cell population prior to the sorting pro-
cess was considered a mixed NP cell population, and the NP cell population after the 
sorting process was considered Tie2+ or Tie2- NP cell populations. 
2.4. NPC Seeding and Incubation with Ang-1 or Ang-2 
In our study, 104 cells/cm2 NPCs were seeded on 12-well plates (#92012, TPP) and 
incubated for 7 days, either within a control medium (CM; LG-MEM) or supplemented 
medium (LG-MEM with either angiopoietin-1 or angiopoietin-2 (#130-06 and #130-07, re-
spectively, Peprotech) at a concentration of 10 ng/mL, 50 ng/mL, and 100 ng/mL). For each 
donor, the plates were prepared as duplicates, such that one plate per condition could be 
tested under a normoxic condition (21% of O2) and the second plate was tested under 2% 
O2 hypoxia (Invivo2 400 #0612NCF05, Ruskinn Technology Ltd., London, U.K.). 
2.5. Resazurin Sodium Salt Cell Activity Assay 
The resazurin sodium salt (#R7017-1G, Sigma-Aldrich) assay was performed at a con-
centration of 10 μg/mL added to the respective medium for 4 h at 37 °C under normoxic 
or hypoxic conditions, respectively. All test conditions were run in triplicate (#655101_100, 
Greiner Bio-One, St. Gallen, Switzerland). The fluorescence signal was quantified with a 
SpectraMax M5 (Molecular Devices, distributed by Bucher Biotec, Switzerland) micro-
plate reader with excitation and emission wavelengths of 560 nm and 600 nm, respec-
tively. The resulting values were normalized to the respective day 7 control sample CM 
without any added growth factors and incubated in normoxia or hypoxia, respectively. 
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2.6. Papain Digestion and DNA Quantification 
The quantity of DNA present in each condition was measured for each sample after 
overnight papain digestion. The absolute amount of DNA was determined, using the 
CyQUANTTM Cell Proliferation Assay Kit (#7026 Molecular Probes, Fisher Scientific) ac-
cording to the manufacturer’s instruction. All test groups were analyzed in triplicate. 
2.7. RNA Extraction and cDNA Synthesis 
The total RNA was isolated from monolayer cultures using the GenEluteTM Mam-
malian Total RNA Miniprep Kit (#RTN70-1KT; Sigma-Aldrich), according to the manu-
facturer’s instruction. The following four steps were performed: releasing of the RNA 
from cells, binding of the RNA to the affinity column, washing to remove contaminants, 
and elution of the purified RNA. The purity of the RNA was assessed by measuring the 
A260/A280 ratio. 
Reverse transcription of total RNA into double-stranded cDNA was performed with 
the High Capacity Reverse Transcription cDNA Kit (Thermo Fisher Scientific, Inc., cat 
#4368814), including 10X RT Buffer, 10X Random Primers, 25X dNTP Mix, and Mul-
tiScribe Reverse Transcriptase (50 U/mL), which were combined into a mastermix with 
additional RNase-free water and the addition of about 500 ng of total RNA.  
2.8. Quantitative Polymerase Chain Reaction (qPCR) 
To study the relative gene expression, cDNA (2 μL) was mixed with the PCR reaction 
solution (2X SYBR green master mix, #B21202; Bimake) containing 0.25 μM specific pri-
mers (Table 2). A real-time quantitative polymerase chain reaction (qPCR) was performed 
using the CFX96TM Real-Time System (#185-5096 C1000 Touch Thermal Cycler; Bio-Rad 
Laboratories) under standard thermal conditions. The qPCR program consisted of a two-
step cycling protocol: an initial denaturation at 95 °C for 5 min, followed by 39 PCR cycles 
at 95 °C for 10 sec, and an annealing temperature of 61 °C for 30 sec. To control the speci-
ficity of the amplification products, a melting curve analysis was carried out for each re-
action. The results were expressed relative to gene expression levels on day 0. Gene ex-
pression was calculated by the 2−ΔΔCt method [27], and the results were normalized to the 
reference genes glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 18S riboso-
mal RNA (18S) expression. All reactions were performed in triplicate. 
Table 2. Overview of human genes used for qPCR using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 18S 
ribosomal RNA (18S) as a reference gene. Genes analyzed for the NPCs: receptor tyrosine kinase (TEK), collagen type II 
(COL2), hypoxia-inducible factor-1α (HIF1A), aggrecan (ACAN). (F = forward, R = reverse). 
Gene Full Gene Name Primer Nucleotide Sequence from 5′ to 3′ 
GAPDH Glyceraldehyde-3-Phosphate Dehydrogenase 
F—ATC TTC CAG GAG CGA GAT  
R—GGA GGC ATT GCT GAT GAT  
18S  18S ribosomal RNA 
F—CGA TGC GGC GGC GTT ATT  
R—TCT GTC AAT CCT GTC GTC CGT GTC C  
TEK TEK Receptor Tyrosine Kinase 
F—TTA GCC AGC TTA GTT CTC TGT GG  
R—AGC ATC AGA TAC AAG AGG TAG GG  
COL2  Collagen Type II 
F—AGC AGC AAG AGC AAG GAG AA  
R—GTA GGA AGG TCA TCT GGA  
HIF1A  Hypoxia Inducible Factor 1 Subunit Alpha 
F—GTC GCT TCG GCC AGT GTG  
R—GGA AAG GCA AGT CCA GAG GTG  
ACAN  Aggrecan F—CAT CAC TGC AGC TGT CAC  
R—AGC AGC ACT ACC TCC TTC  
We first assessed the effect of Ang-1/2 at different concentrations in hypoxia and 
normoxia on the relative expression of two genes that are associated with ECM produc-
tion in the IVD, namely aggrecan (ACAN). We also examined the HIF1A gene, which is 
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the crucial mediator of the adaptive response of cells to hypoxia. Furthermore, to estimate 
the expression of the Tie2 receptor, regarding the effect of the Ang-1/2 proteins and the 
microenvironments (normoxia vs. hypoxia) in the NP cells mixed population, and the NP 
Tie2- and NP Tie2+ cell populations, we analyzed the TEK gene. 
2.9. Statistical Analysis 
Statistics were performed using GraphPad Prism (version 8.0.1 for Windows, 
GraphPad Software; San Diego, California, U.S.A.). All data were initially tested for nor-
mal distribution using the Shapiro–Wilk test. Due to lack of normality a nonparametric 
distribution was then assumed. Statistical significance was determined using the Kruskal–
Wallis’s test followed by the Sidak’s multiple comparison test. Results were presented as 
mean ± standard deviation (SD). A p-value < 0.05 was considered significant. Asterisks 
within figures denote the degree of statistical relevance observed: * < 0.05; ** < 0.01; *** < 
0.001; **** < 0.0001. 
3. Results 
3.1. Effect of Oxygen Tension and Angiopoietin-1/2 on NP Cell’s Proliferation  
To explore the role of Ang-1 and Ang-2 in cell proliferation on the three NP cells 
populations (namely, Tie2+, Tie2-and mixed populations) we assessed the amount of DNA 
under normoxic and hypoxic conditions for the NP cells mixed, NP Tie2- cells, and NP 
Tie2+ cells populations (Figure 1). 
 
Figure 1. Amount of DNA measured of NP cells populations under normoxia and hypoxia assessed by Hoechst DNA 
assay on Day 7. Ang-1 and Ang-2 were administrated in three concentrations: 10, 50 and 100 ng/mL. The control Day 0 
samples were used as reference. (a) Amount of DNA measured of NP cells mixed population (N = 7); (b) amount of DNA 
measured of NP cells Tie2- population (N = 3); (c) amount of DNA measured of NP cells Tie2+ population (N = 2). Bars 
represent mean ± SD. A p-value < 0.05 was considered significant. Asterisks within figures denote the degree of statistical 
relevance observed: * < 0.05; ** < 0.01; **** < 0.0001. 
Concerning the NP cells mixed population (Figure 1a), under normoxic conditions, 
the control Day 7 and the stimulated samples showed a significant decrease in their 
amount of DNA in a range of 35 to 47%, compared to the control Day 0 sample. However, 
all the samples did not show any significant differences in their amount of DNA, com-
pared to the Day 0 control sample in hypoxia. Moreover, over the whole NP cells mixed 
population, no concentration-dependent or protein-dependent trends were apparent. 
In the NPCs Tie2- population (Figure 1b), a slight upregulation in the amount of DNA 
was observed in every sample, in normoxia and hypoxia, compared to the Day 0 sample. 
In normoxia, the amount of DNA was increased up to 1.5 folds and in hypoxia, it was 
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increased 1.25- to 1.6-fold. However, no concentration-dependent or O2-dependent effect 
or trend was detectable for any sample condition, treated or either untreated with Ang-1 
or Ang-2. 
The entire collection of samples treated in the NP cells Tie2+ population (Figure 1c) 
showed an increased amount of DNA, compared to the Day 0 sample. However, no con-
centration-dependent stimulation or protein-dependent effect was observable either in 
normoxia. In the hypoxic condition, only the sample treated with Ang-1 at (10 ng/mL) 
showed a significant increase in their amount of DNA compared to the control. 
3.2. Effect of Oxygen Tension and Angiopoietin-1/2 on NP Single Cell’s Metabolism 
Further, we examined the metabolic activity/DNA ratio at Day 7, which is the most 
relevant parameter, as it refers to single-cell metabolic activity (Figure 2). 
 
Figure 2. Metabolic activity on single-cell level of NP cells populations in normoxia and hypoxia on Day 7. Ang-1 and 
Ang-2 were administrated in three concentrations: 10, 50 and 100 ng/mL. The control Day 7 samples were used as refer-
ence. (a) Metabolic activity on single-cell level of NP cells mixed population; (b) metabolic activity on single-cell level of 
NP cells Tie2- population; (c) metabolic activity on single-cell level of NP cells Tie2+ population. Bars represent mean ± SD. 
A p-value < 0.05 was considered significant. Asterisks within figures denote the degree of statistical relevance observed: * 
< 0.05; ** < 0.01; *** < 0.001; **** < 0.0001. 
In the NP mixed population under normoxic conditions, the stimulated samples 
showed a 2- to 3-fold increase in the metabolism/DNA ratio, compared with the Day 7 
control sample. In summary, for normoxia, a stimulation effect was detectable, but not 
specifically in concentration- or protein-dependency (Figure 2a). Furthermore, in hypoxic 
conditions, for the NP mixed population, the stimulated samples all presented an increase 
in their ratio metabolism/DNA, as they were 4 to 8 times higher than in normoxic condi-
tions. Hence, no clear trend in concentration- or protein-dependency was observable. 
Concerning the Ang-1 stimulated samples, the metabolism/DNA ratio increased from 10 
to 50 ng/mL concentrations and then decreased for the 100 ng/mL sample, with a signifi-
cant increase for Ang-1 at 50 and 100 ng/mL. Regarding the Ang-2 treated samples, the 
metabolism/DNA ratio decreased from 10 to 50 ng/mL and then increased again for the 
Ang-2 for the 100 ng/mL treated sample, with a significant increase for Ang-2 at 10 and 
100 ng/mL. 
For the NP Tie2- cells population under normoxic condition, the ratios of the Ang-2 
at 10 ng/mL and the Ang-1 at 50 ng/mL samples were 3- to 3.5-fold increased, compared 
to the Day 7 control sample (Figure 3b). For the other Ang-1 or Ang-2 treated samples, the 
ratios stayed at an equal level to the Day 7 control sample, or they even decreased. In 
hypoxia, all the stimulated samples showed a decrease in their metabolism/DNA ratio, 
except for the Ang-2 at the 100 ng/mL sample, whose ratio stayed at a similar level to the 
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Day 7 control sample. as Additionally, for the mixed population, no trend in the effect of 
the concentration, nor the protein, was assessable. The Ang-1 treated samples presented 
an increase in their metabolism from the 10 to 50 ng/mL samples and then a decrease to 
the 100 ng/mL sample. The Ang-2 treated samples showed a decrease from the 10 ng/mL 
sample to the 50 ng/mL sample and then an increase to the 100 ng/mL sample. However, 
no significant increase or decrease was detected. 
In the NP Tie2+ cells population, we observed a similar ratio for all the samples in 
normoxia, either stimulated with Ang-1/2 or not (Figure 2c). The same picture was present 
in hypoxia. All samples showed similar or slightly elevated ratios, compared to the day 7 
control sample, except for the Ang-2 at the 10 ng/mL sample, which significantly de-
creased in its ratio, compared to the control sample. Therefore, a significant increase in 
stimulation with Ang-1 at 50 ng/mL and Ang-2 at 10, 50 and 100 ng/mL was detected. 
3.3. Effect of Oxygen Tension and Angiopoietin-1/2 on ECM Related-Genes  
3.3.1. Analysis of Aggrecan Relative Gene Expression 
Concerning the relative gene expression of ACAN for the NP cells mixed population, 
we did not observe any significant difference for normoxia, compared to the control con-
dition (Figure 3a). No effects were detected in a dose-dependent manner for angiopoietin 
on the relative gene expression nor for specific variation in the use of Ang-1 or Ang-2. 
Nonetheless, all treated samples, either with Ang-1 or Ang-2, showed an equal amount of 
ACAN as the control samples, or at least a 2- to 3-fold increase in their ACAN relative 
expression. However, Ang-2 samples at 100 ng/mL in normoxia presented a downregula-
tion in their ACAN gene expression. 
 
Figure 3. Relative gene expression of the three NP cells populations, comparing the effect of Ang1/2 at different concen-
trations in normoxia and hypoxia on the ACAN gene expression. The control (Day 0) samples were used as reference (set 
at 1). Ang-1 and Ang-2 were administrated in three concentrations: 10, 50 and 100 ng/mL. (a) ACAN relative gene expres-
sion of NP cells mixed population; (b) ACAN relative gene expression of NP cells Tie2- population; (c) ACAN relative 
gene expression of NP cells Tie2+ population. Bars represent mean ± SD. 
Like the NP cells mixed population, the control Day 0 and control Day 7 samples 
showed non-significant differences in their relative expression of ACAN in normoxia and 
hypoxia for the NP cells Tie2- population (Figure 3b). However, a remarkable effect in a 
dose-dependent manner was detectable for the Ang-1/2 sample at 10 ng/mL in normoxia, 
the Ang-1 sample at 100 ng/mL in normoxia and hypoxia, and the Ang-2 sample at 100 
ng/mL in hypoxia. 
The NP cells mixed, NP Tie2- cells, and NP Tie2+ cells populations showed no differ-
ences in the gene expression of ACAN, compared to the control Day 0 (Figure 3c). We 
detected no specific variation in the use of Ang-1 or Ang-2 in normoxia and hypoxia but 
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detected a dose-dependent increase in relative gene expression for hypoxia. In normoxia, 
we detected no effect in a dose-dependent manner of angiopoietin on the relative gene 
expression or specific variation in the use of Ang-1 or Ang-2. All the stimulated samples 
in normoxia were downregulated in their ACAN gene expression by 40 to 75%, compared 
to the control Day 0 sample. 
3.3.2. Analysis of Collagen Type II Relative Gene Expression 
The relative gene expression of COL2 for every sample in normoxia and hypoxia in-
creased compared to the control Day 0 sample (Figure 4a). The peak values in COL2 rela-
tive gene expression compared to the control Day 0 sample were reached on a significant 
level in the Ang-1 and Ang-2 at 10 ng/mL treated samples in normoxic condition. All stim-
ulated hypoxia samples and the control Day 7 sample showed a 2- to 2.5-fold increase in 
their COL2 relative gene expression. Thus, we detected no effect in a dose-dependent 
manner of angiopoietin on the relative gene expression or specific variation in the use of 
Ang-1 or Ang-2 in hypoxia. 
 
Figure 4. Relative gene expression of the three NP cells populations, comparing the effect of Ang1/2 at different concen-
trations in normoxia and hypoxia on the COL2 gene expression. The control (Day 0) samples were used as reference (set 
at 1). Ang-1 and Ang-2 were administrated in three concentrations: 10, 50 and 100 ng/mL. (a) COL2 relative gene expres-
sion of NP cells mixed population; (b) COL2 relative gene expression of NP cells Tie2- population; (c) COL2 relative gene 
expression of NP cells Tie2+ population. Bars represent mean ± SD. A p-value < 0.05 was considered significant. Asterisks 
within figures denote the degree of statistical relevance observed: ** < 0.01; **** < 0.0001. 
The COL2 relative gene expression for the Ang-1/2 at 10 ng/mL and Ang-1 at 100 
ng/mL sample in normoxia followed the same patterns concerning the peak values as de-
scribed above (Figure 4b). The NP Tie2- population showed a similar relative gene expres-
sion, compared to the NP cells mixed population for the control day 7 sample and the 
Ang-2 at 100 ng/mL sample in normoxia and hypoxia. As showed previously in the NP 
cells mixed population, the effect of the stimulation of the 10 ng/mL concentration for 
Ang-1 and Ang-2 in normoxia is noteworthy. Additionally, the Ang-1 at 100 ng/mL sam-
ple reacted remarkably to its stimulation in normoxia and hypoxia. For all the other sam-
ples, no trend in the Ang-1 and Ang-2 administration was detectable. 
Concerning the NP Tie2+ population in normoxia, all the stimulated samples, as well 
as the control Day 7 sample, showed a 1.5- to 2.5-fold increase in their COL2 relative gene 
expression, compared to the normoxia control Day 0 sample (Figure 4c). In hypoxia only, 
the control Day 7 sample with a 3.5-fold increase and the Ang-1/2 at 10 ng/mL sample 
with a 2- to 2.25-fold increase in their COL2 relative gene expression showed a difference, 
compared to their control Day 0 sample. Interestingly, the 10 ng/mL concentration for 
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Ang-1 and Ang-2 did not provoke a remarkable difference in the gene expression for 
normoxia as it did in the NP cells mixed population and the NP cells Tie2- population, 
compared to the normoxia control Day 0 sample. Summing up, the unstimulated control 
Day 7 sample in hypoxia reached the highest COL2 gene expression in the NP cells Tie2+ 
population.  
3.4. Effect of Oxygen Tension and Angiopoietin-1/2 on Oxygen Level Related-Genes 
Analysis of Hypoxia-Inducible Factor 1-Alpha Relative Gene Expression 
The HIF1A relative gene expression in NP cells mixed population presented a similar 
trend, compared to the COL2 relative gene expression in the NP cells mixed population. 
As in the COL2 relative gene expression of NP cells mixed and NP Tie2- cells populations, 
the 10 ng/mL stimulation in normoxia of the Ang-1 and Ang-2 samples reached, also in 
this population, the highest amount of relative gene expression (Figure 5a). All stimulated 
hypoxia samples and the control Day 7 sample range in a 10% decrease and increase 
around the baseline in their COL2 relative gene expression. Thus, we detected no effect in 
a dose-dependent manner of angiopoietin on the relative gene expression or specific var-
iation in the use of Ang-1 or Ang-2 in hypoxia. However, the stimulation in normoxia 
clearly induced a higher potency than in hypoxia for 4 out of the 6 samples, whereas, 
again, no clear trend in concentration- or protein-dependency could be evaluated. 
 
Figure 5. Relative gene expression of the three NP cells populations, comparing the effect of Ang1/2 at different concen-
trations in normoxia and hypoxia on the HIF1α gene expression. The control (Day 0) samples were used as reference (set 
at 1). Ang-1 and Ang-2 were administrated in three concentrations: 10, 50 and 100 ng/mL. (a) HIF1α relative gene expres-
sion of NP cells mixed population; (b) HIF1α relative gene expression of NP cells Tie2- population; (c) HIF1α relative gene 
expression of NP cells Tie2+ population. Bars represent mean ± SD. A p-value < 0.05 was considered significant. Asterisks 
within figures denote the degree of statistical relevance observed: * < 0.05. 
The normoxia associated samples of the Ang-1 and Ang-2 at 10 ng/mL concentrations 
reached a 12-fold and 15-fold increase in their HIF1A relative gene expression, compared 
to the control Day 0 sample (Figure 5b). Remarkably, similar to the NP cells mixed popu-
lation, the NP Tie2- cells population showed a similar pattern in relative gene expression, 
compared to the COL2 relative gene expression within the NP Tie2- cells population. It is 
also worth mentioning that the Ang-2 at 50 ng/mL and the Ang-1 at 100 ng/mL samples 
achieved the highest effect in stimulation in hypoxia for both COL2 and HIF1A relative 
gene expression within the NP cells Tie2- population. 
In the NP cells Tie2+ population (Figure 5c), the incubation with Ang-1 and Ang-2 in 
their different concentrations does not seem to have any effect on the relative HIF1A gene 
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expression. Notably, all of the stimulated samples showed downregulation in their gene 
expression, compared to the control conditions at Day 0. 
3.5. Effect of oxygen tension and Angiopoietin-1/2 on NP progenitor cells related-genes 
Analysis of angiopoietin-1 receptor relative gene expression  
In the NP cells mixed population, all stimulated samples in normoxia, as well as in 
hypoxia, showed an increase in their gene expression (Figure 6a). With a stimulation dose 
of 10 ng/mL for Ang-1/2, the gene expression in normoxia reached two peak values: the 
Ang-1 at 10 ng/mL sample presents a statistically relevant 400-fold increase and the Ang-
2 at 10 ng/mL sample, a 200-fold upregulation of their TEK gene expression, compared to 
their control Day 0 sample. Thus, in this population, again, the 10 ng/mL dose in normoxia 
reached the highest values in gene expression. However, in hypoxia, no trend in gene 
expression upon stimulation by Ang-1 or Ang-2 and their different concentrations were 
detectable. 
 
Figure 6. Relative gene expression of the three NP cells populations, comparing the effect of Ang-1/2 at different concen-
trations in normoxia and hypoxia on the TEK gene expression. The control (Day 0) samples were used as reference (set at 
1). Ang-1 and Ang-2 were administrated in three concentrations: 10, 50 and 100 ng/mL. (a) TEK relative gene expression 
of NP cells mixed population; (b) TEK relative gene expression of NP cells Tie2- population; (c) TEK relative gene expres-
sion of NP cells Tie2+ population. Bars represent mean ± SD. A p-value < 0.05 was considered significant. Asterisks within 
figures denote the degree of statistical relevance observed: * < 0.05. 
Concerning the NP cells Tie2- population (Figure 6b), no clear trends in dose-depend-
ency nor protein-dependency are detectable. In normoxia, for all the NP cells Tie2+ sam-
ples treated with Ang-1 or Ang-2 and including the Day 7 control sample, the TEK relative 
gene expression was increased up to 2-fold, compared to the control Day 0 equivalent 
(Figure 6c). Therefore, normoxia upregulated the gene expression slightly. Yet, the stim-
ulation with Ang-1 or Ang-2 in its different doses did not have any effect in normoxia, as 
the gene expression stays in a similar range for all normoxia samples. In addition, in the 
hypoxic condition, the stimulation did not have any upregulating effect. This missing re-
action to stimulation in hypoxia was further confirmed by the control day 7 sample, which 
reached the maximum value of TEK relative gene expression for this population. 
4. Discussion 
Our study showed that the three different cells population studied here and present 
in the NP tissue act/behave differently in hypoxic and normoxic conditions. The increase 
in the O2 tension significantly decreases the NP cells mixed population proliferation, 
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while, conversely, we observed an increase in proliferation of the NP cells Tie2+ popula-
tion. Concerning the cell’s activity, the decrease in the O2 tension induced an increase in 
the cell’s metabolism for the NP cells mixed and Tie2+ populations. 
Additionally, the three NP cells population showed variation in their phenotype/gen-
otype, according to the presence of Ang-1 or Ang-2 in combination with normoxic or hy-
poxic conditions. To our knowledge, no other studies are comparing the influence of the 
oxygen tension combined on three distinct cells population, well-characterized in the hu-
man NP tissue, including NP progenitor cells. Moreover, to the best of our knowledge, as 
of today, there is no literature published about the different components of the heteroge-
neous NP tissue cell’s population, including NPPCs isolated from relatively young and 
healthy IVDs in relation to the activation of the receptor-ligand system Tie2/Ang. 
4.1. Ang-1/2 and Its Effect on DNA Measurement in Normoxic and Hypoxic Conditions 
Evidence has arisen in recent years suggesting that a tissue renin–angiotensin system 
(tRAS) is involved in the progression of various human diseases [28], including IVD de-
generation [29]. Numerous reports and studies showed the positive effects of pathologic 
tRAS pathway inhibition and protective tRAS pathway stimulation on the treatment of 
cardiovascular, inflammatory, and autoimmune disease and the progression of neuro-
pathic pain. Cell proliferation, senescence, and aging are known to be related to RAS path-
ways. In this context, the DNA concentration measured in our study in all the NP cells 
mixed and Tie2+ population samples cultured within normoxic conditions were statisti-
cally different from the controls at Day 0. None of the samples in the NP cells Tie2- popu-
lation showed statistically significant differences. The amount of DNA in the NP cells 
mixed population decreased, whereas the amount was increased in the NP cells Tie2+ pop-
ulation on Day 7 for the control and the stimulated samples in normoxia, compared to 
their control Day 0 equivalents. In hypoxia, no effect on the proliferation was detected, 
except for the NP cells Tie2+ population treated with Ang-1 at 10 ng/mL. 
In the NP cells Tie2- population, a slight upregulation in the amount of DNA was 
seen in every sample, in normoxia and hypoxia, compared to the Day 0 sample. The rea-
son for this discrepancy between the NP cells mixed and NP Tie2- cells populations is not 
clear. As the NP cells mixed population consists of 95 to 99% of the exact cell types as the 
Tie2- cells population, the 1 to 5% difference in cell type should not provoke the observed 
difference [1]. Furthermore, both samples underwent the same schedule of incubation and 
medium change, which should result in a more similar outcome. However, a possible cell-
to-cell interaction or co-culture between the Tie2+ and Tie2- cells within the mixed popu-
lation could influence the proliferation as shown in other tissue and cell types [30,31]. 
All samples treated in the NP cells Tie2+ population showed an increased amount of 
DNA, compared to the Day 0 sample and a trend of higher amounts of DNA in normoxia, 
compared to hypoxia. A possible explanation for the lower amount of DNA detected 
within the cells population incubated under hypoxic conditions, compared to the 
normoxic condition, could be the potential differentiation within the chondrogenic line-
age of the cells in hypoxia, reducing, at the same time, cell proliferation. As described by 
Lyu et al. [12], an explanation could be that hypoxia can exert either positive or negative 
effects on IVD progenitor cells. In particular, hypoxia can inhibit proliferation and induce 
apoptosis but might also promote the chondrogenic differentiation of IVD progenitor 
cells. Huang et al. [32] identified tissue-specific intervertebral disc progenitor cells (DPCs) 
from healthy Rhesus monkeys; in particular, they found that they are sensitive to low 
oxygen tension and undergo apoptosis under hypoxic conditions due to their inability to 
induce/stabilize hypoxia-inducible factors (HIF). These results confirm our findings. Our 
findings and the findings of the previously mentioned studies contradict the publication 
of Tekari et al. [13], who found a better cell survival of Tie2+ cells cultured in hypoxia (2%), 
which were based on young-aged bovine cells. 
We identified in our results a trend for an increased amount of DNA in normoxia for 
the NP Tie2+ population. These are contradictory findings to several studies, in which it 
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was shown that an oxemic shift would be expected to lead to a failure in progenitor cell 
activation [13,33]. The variation in oxygen tension is possibly mediated by alterations in 
the vascular supply to the endplate cartilage or even the annulus fibrosus. In turn, the 
cells no longer reside in their native associated microenvironment and are associated with 
a reduced cell proliferation capacity [34–36]. 
Concerning the amount of DNA, we detected either no effect in a dose-dependent 
manner of angiopoietin or specific variation in the use of Ang-1 or Ang-2 in normoxia and 
hypoxia for the three tested populations. Sakai et al. [1] demonstrated selective enhance-
ment of the proliferation of Tie2+ GD2- CD24- (i.e., Tie2 single-cell sorted positive cells 
(T/sp)) and of Tie2+ GD2+ CD24- (i.e., Tie2 single-positive cells (TG/dp)) by using a co-
culture with a cells feeder layer (murine stromal cells overexpressing human Ang-1 
(AHESS-5). A marked Ang-1 dependent growth resulted in increased proliferation of the 
T/sp population by 3.1 ± 0.4 times and for the TG/dp population by 3.2 ± 0.4 times. Unfor-
tunately, no information about the administrated Ang-1 dose or incubation time was pub-
lished. Nevertheless, these results could not be confirmed with the NP cells Tie2+ popula-
tion in this study. A possible explanation could be that the Tie2 receptor was not expressed 
anymore over in vitro culture time, as cells needed expansion before starting the experi-
ment. Summing up, at the time of incubation with Ang-1 and Ang-2, the cells were sup-
posedly not Tie2+ progenitor cells anymore, and therefore could not react to any stimula-
tion, as the receptor for our ligands was not present anymore.  
Ligand-deficient Ang1-/- or receptor-deficient Tie2-/- is embryonically lethal for trans-
genic mice. Both deletions showed common features in their phenotype, and both failed 
to develop a fully functional cardiovascular system [4]. Vasculogenesis proceeds nor-
mally, but remodeling and maturation of the vessels are defective [24]. Ang-2-deficient 
mice seem phenotypically normal at birth but die within 14 days or develop normally 
throughout adulthood. On the other hand, systemic embryonic Ang-2 overexpression re-
sults in an embryonic lethal phenotype of Ang-2 transgenic mice [18].  
Furthermore, Wang et al. [37] determined the role of Ang-2 in the pathology of IVDD. 
They verified the expression of Ang-2 in human degenerative NPC and showed that Ang-
2 expression was considerably higher in severe IVDD than in mild IVDD. Additionally, 
they demonstrated that NP cells treated with exogeneous Ang-2 resulted in marked 
downregulation of type II collagen and aggrecan and a significant increase in the expres-
sion of MMP13, ADAMTS4, and the pro-inflammatory cytokine IL-1β, both on protein 
and mRNA levels. The resulting dysregulation in ECM degradation in NPCs upon Ang-
2 exposure contributed to the pathogenesis of IVDD. Conclusively, the study reveals Ang-
2 inhibition as a potential novel therapeutic target for IVDD treatment. 
4.2. Ang-1/2 and Its Effect on Metabolic Activity per DNA in Normoxic & Hypoxic Conditions 
Out of all analyses, in cell metabolism relative to DNA amount, the difference be-
tween oxygen tension (≤ 5% vs. 21%) was in favor of hypoxia for every single sample 
tested in our three populations of interest, i.e., NP cells mixed, NP cells Tie2-, and NP cells 
Tie2+ populations. In our study, the samples in the hypoxic environment all achieved a 
higher metabolism, compared to the normoxic environment. This is in accordance with 
previous studies upon oxygen levels in NPC cultures, such as those of Feng et al. [38], 
Mwale et al. [39], Stoyanov et al. [40], and Gantenbein et al. [31]. The authors demon-
strated that hypoxia enhances NPCs phenotype, which results in greater ECM compo-
nents production and, indeed, a higher metabolism. 
Additionally, as the NP cells mixed population and NP Tie2- cells population only 
differ in 1 to 5% of their cell population (only depletion of Tie2+ cells), this could explain 
that stimulated samples showed comparable values in their metabolic activity [6]. In con-
trast, the NP cells Tie2+ population responded in higher potency to the normoxic and hy-
poxic environments, compared to the two others population (i.e., mixed and Tie2-). On 
one hand, the upregulation of the cell’s metabolism would therefore seem logical, as this 
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population expresses the Tie2 receptor and thus can react to the stimulation (i.e., pres-
ence/absence of Ang) by its ligands Ang-1 and Ang-2. However, on the other hand, the 
stimulation effect remains in question, as the treated samples do not show any trend either 
in a dose- or protein-dependent manner. 
According to the findings of Wang et al. [23], Ang-2 plays a role in suppressing cell 
adhesion, decreasing cell viability, and promoting NP cell apoptosis. Concerning the cell’s 
metabolism, in our study, the findings for Ang-2 could not be confirmed, which supports 
the aforementioned lack of effect upon Ang-1 and Ang-2 stimulation. Thus, the more re-
liable and convincing explanation for the upregulation of fluorescence intensity (i.e., cell’s 
metabolism) in the NP cells Tie2+ population in normoxia and hypoxia, compared to the 
NP cells mixed and NP cells Tie2+ populations, could potentially be that progenitor cells 
show a higher metabolism, compared to mature cells [41]. 
Another aspect that has to be taken into consideration by comparing the findings of 
Wang et al. [23] with our study is that the cells from our study were isolated from trauma 
discs and not from degenerated IVDs. Thus, the cells in Wang’s study were already stim-
ulated by Ang-1, due to potential blood vessel infiltration and inflammation in the degen-
erated disc as well as by Ang-2, as the Ang-2/Ang-1 ratio increases in degenerated discs 
for the same reason [37]. Whether such contradictory findings could be related to differ-
ences in IVD degeneration pathways between injuries (trauma), natural aging, or the de-
gree of IVD degeneration is still unclear. 
4.3. Ang-1/2 and Its Effect on the ECM Gene Expression in Normoxia & Hypoxia 
Looking at the gene expression levels, we did not observe significant results between 
normoxia and hypoxia for the majority of the samples. The effect of hypoxia on gene ex-
pression associated with chondrogenic lineage and ECM production in the IVD is already 
well documented in the literature [38,39]. At least, in the NP cell Tie2+ population for 
ACAN, we detected a trend of upregulation in hypoxia, whereas for COL2, it was not the 
case. If Ang-1 and/or Ang-2 had a stimulatory effect, this would be the case for the NP 
cells Tie2+ population, as this population has the Tie2 receptor for the binding of the Ang-
ligands. It is, therefore, astonishing and unexpected to find the highest upregulations for 
ACAN in normoxia in the NP cells mixed and Tie2- populations for Ang-1/2 at 10 ng/mL 
and Ang-1 at 100 ng/mL. A possible explanation for these particular increases could be 
related to any cross-reactions of the ligands Ang-1 and Ang-2 with another receptor. This 
hypothesis is difficult to defend in the sense that there are only two or three out of the six 
treated samples in normoxia that show an effect upon stimulation. 
However, the main explanation for the stimulation of Ang-1 and Ang-2 not having 
any effect is the outcome for the NP cells Tie2+ population. The stimulation did not show 
any differences upon Ang-1 or Ang-2 protein stimulation, including their different con-
centrations. In the case of the NP cells Tie2+ population, several explanations can be con-
sidered. First, there could have been a cross-reaction of the Tie2 receptor with other lig-
ands, which subsequently blocked the binding of Ang-1/2 to the receptor and thus the 
downstream pathways. Second, it would be possible that the Tie2 receptor was not ex-
pressed after the expansion culture phase. Briefly, at the time of incubation with Ang-1 
and Ang-2, the cells were not Tie2+ progenitor cells anymore. To confirm the progenitor 
state of the cell right before the start of the experiment, another FACS analysis could have 
been performed. Third, the first FACS analysis itself could already have stressed the cells 
and favored the loss of their progenitor attributes. 
The hypothesis for the lack of effect of Ang stimulation is encouraged by the exami-
nation of the TEK gene. It is eminently important to see that, similar to ACAN and COL2, 
we did miss out on any specific reaction in the relative gene expression of TEK to either 
Ang-1, Ang-2, including their three different doses in the Tie2+ cells population. This is 
unexpected for the same reasons as already mentioned for ACAN and COL2. In the NP 
mixed and NP Tie2- cells populations, the relative gene expression in TEK and HIF1A do 
show the same patterns as COL2 and ACAN. The peak values in normoxia deserve special 
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mention, such as Ang-1/2 at 10 ng/mL and Ang 1 at 100 ng/mL. However, again, it was 
unexpected to find such upregulation in normoxia of the genes within the NP mixed and 
NP cells Tie2- populations. As we find the same pattern several times, there must be at-
tractive or favorable attributes for these doses in normoxia. Up to that point, explanations 
remain elusive. As already mentioned before, the data must be interpreted with caution, 
due to the high donor variation. The downregulation of HIF1A in hypoxia in the NP cells 
mixed, NP cells Tie2- and Tie2+ populations can be explained, as hypoxia progressively 
decreases HIF1A expression at the mRNA level, due to the mRNA-destabilizing protein 
tristetraprolin [42]. 
However, Huang et al. [32] detected that the level of relative gene expression of 
HIF1A for DPCs of the NP remained constant under hypoxia, compared to normoxia. 
They suggest that incompetency of the DPCs of the NP to adapt to oxygen tension may 
be in part due to the inability to upregulate HIF expression. Their findings are consistent 
with our results of the HIF1A relative gene expression of the NP cells Tie2+ population. 
4.4. Study Weaknesses and Limitations 
One of the main limitations of this study was the relatively small sample size for the 
NP cells Tie2+ population. Sample expansion of the NP progenitor cells after a sorting 
process was a challenge, due to the relatively low percentage who represent this popula-
tion in the NP tissue, and future studies should recruit IVD material from bigger cohorts 
and multiple populations and etiologies. Moreover, previous studies demonstrated the 
difficulties to expand, in vitro, this population [16,43]. Additionally, the “controls” used 
in the study were not truly healthy IVDs, as they were traumatic discs. In this respect, a 
comparison of fresh cadaveric IVD material of undegenerated nature would be essential 
for any future investigations. Moreover, the 2D culture was shown to not be the most 
accurate system for culture and expansion of NP progenitor cells [16]. Previous studies, 
such as that of Sakai et al., dealt with only Tie2+ cells from degenerated discs; Wang et al. 
investigated the effect of Ang-2 in degenerated discs. It remains unclear whether the Tie2+ 
cells from the degenerated or the trauma discs react in a comparable way upon Ang stim-
ulation. Thus, it remains unclear whether we can compare our results (cells isolated from 
trauma patients) to the results from publications based on degenerated discs. We suspect 
that the results from degenerated discs are potentially biased, as discs subjected to degen-
eration present a higher Ang-2/Ang-1 ratio than healthy discs [23], and the Ang-1 release 
should be increased as the degenerated discs present blood vessels ingrowth. 
Another strong limitation of the study is that we only used the Tie2- population as a 
control population. Previous studies [1,37] investigated Tie2 blocking antibodies as a neg-
ative control. For our study, a second negative control with a Tie2 blocking antibody 
would have made sense, as we observed, especially in the qPCR analysis, the effects in 
normoxia for Ang-1/2 at 10 ng/mL and Ang-1 at 100 ng/mL. Alternatively, other small 
inhibitory molecules could have been tested, which are known to interfere and block the 
Ang-1 and/or Ang-2 receptors. These inhibitors could have been tested by adding these in 
equimolar concentrations or by titration approaches. These are important negative con-
trols that were not considered here. 
4.5. Outlook and Clinical Relevance 
In this study, we used human NP cells isolated from trauma patients’ IVDs. We 
demonstrated the significant impact of culturing NP cells under hypoxic conditions to 
improve the proliferation, metabolism and gene expression of NP progenitor cells. How-
ever, no impact or effects were observed concerning the implementation of Ang-1 or Ang-
2 in our culture medium.  
The ensuing findings could directly impact clinical and therapeutic strategies in con-
trast to preclinical studies in other species that often need to be verified in humans first. 
Additionally, we provided novel evidence that culture within a hypoxic environment can 
drastically influence the proliferation, metabolism, and gene expression of the different 
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cell populations present in human NP tissue. Moreover, we demonstrated that the hy-
poxic conditions affect more the progenitor cell populations from the human NP tissue 
(also known as Tie2+) than the two other populations (mixed and Tie2-). All those findings 
could lead to a new way to culture NP progenitors cells prior to clinical applications. Sev-
eral studies have demonstrated Ang-1 and Ang-2 act in a concentration-dependent man-
ner [17,44–47]. Beyond the crucial role in blood vessel development, recent studies suggest 
a broader role for Tie2, and the importance of Ang-1 and Ang-2 seem to be evident, as 
they are ligands (agonists) of the Tie2+ receptor and, therefore, expressed in NPPC. Nev-
ertheless, previous studies, such as those of Sakai et al. and Wang et al., demonstrated the 
effects of Ang-1 on cell proliferation and of Ang-2 on cell viability and cell adhesion. Their 
findings prompt us to clarify the favorable methods, adjust and improve our study design, 
and to further investigate the effects of Ang-1 and Ang-2 on NP cells. Despite our results, 
Ang-1 and Ang-2 may constitute a novel therapeutic target for the treatment of IVDD. A 
better understanding of the influence of Ang-1 and Ang-2 on the NPPCs would be of em-
inent importance in the context of IVD tissue engineering and regenerative medicine. 
Other parameters that could have been taken into consideration as well are the GAG 
content, and the measurement of inflammatory cytokines. Moreover, HIF1A should be 
investigated at the protein level with Western blot analysis or immunohistology, as the 
HIF1A mRNA expression could have a fast turnover, especially in prolonged hypoxia 
[42].  
5. Conclusions 
• To the best of our knowledge, this study cannot provide evidence for stimulation of 
Ang-1 or Ang-2 or their dose-dependent administration influences on NP cell prolif-
eration. 
• Neither on the NP cell’s metabolism, or relative gene expression. 
• However, our study demonstrated that hypoxia enhances NP cells phenotype, which 
resulted in greater ECM components production, in accordance with Feng et al. [38] 
and Mwale et al. [39]. 
• Moreover, we also demonstrated a higher NP cell metabolism if cultured in hypoxia.  
• Regarding the differences in Tie2+ cell proliferation upon normoxia and hypoxia, our 
results confirmed the studies by Lyu et al. [12] and Huang et al. [32]. 
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